Is Perspective Therapeutics, Inc. (CATX) a Buy, Sell, or Hold?
AMEX : CATX
Perspective Therapeutics, Inc. — Analyst Ratings
$3 USD
$0.03 (1.01%)
- Volume
- 939.5K
- Average Volume
- 1.75M
- Market Capitalization
- $342.14M
- P/E Ratio
- -0.11
- Dividend Yield
- 0.00%
- Price Target
- $14.00
- Year High
- $6.16
- Year Low
- $1.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.75
Analyst Consensus Summary
Consensus Rating
Neutral
11 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-78.6%
vs Current Price
Price Target
$14.00
Average TargetPrice Target Range
Lowest Target
$12.00
-75.0% DOWNSIDE
Average Target
$14.00
Median Estimate
Highest Target
$16.00
-81.3% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 11
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 9 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Truist Financial | Greg Renza | $12 | $5.09 | 2026-03-17 08:35 AM | 135.8% |
| Piper Sandler | Biren Amin | $16 | $5.03 | 2026-02-19 05:11 AM | 218.1% |
| UBS | David Lai | $7 | $2.12 | 2025-11-20 07:26 PM | 230.2% |
| BTIG | Jeet Mukherjee | $14 | $4.2 | 2025-10-10 06:59 AM | 233.3% |
| UBS | David Dai | $20 | $11.69 | 2024-10-23 11:50 PM | 71.1% |
| Oppenheimer | Jeff Jones | $22 | $12.66 | 2024-10-14 02:07 AM | 73.8% |
| Truist Financial | Nicole Germino | $21 | $12.28 | 2024-09-25 02:10 AM | 71.0% |
| Bank of America Securities | Alec Stranahan | $24 | $12.82 | 2024-07-25 02:11 AM | 87.2% |
| Oppenheimer | Jeff Jones | $19 | $11.93 | 2024-06-18 03:26 AM | 59.3% |